CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerability
Mehdi Rabiee Valashedi, Amaneh Mohammadi Roushandeh, Kazuo Tomita, Yoshikazu Kuwahara, Zahra Pourmohammadi-Bejarpasi, Pouya Safarzadeh Kozani, Tomoaki Sato, Mehryar Habibi Roudkenar
Topics & Concepts
CRISPRVulnerability (computing)CisplatinBreast cancerCancer researchHuman breastBiologyCancerGeneticsGeneComputer securityComputer scienceChemotherapyFerroptosis and cancer prognosisClusterin in disease pathologyTrace Elements in Health